EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52012AE0469
Opinion of the European Economic and Social Committee on the ‘Amended Proposal for a Directive of the European Parliament and of the Council Amending Directive 2001/83/EC, as regards information to the general public on medicinal products subject to medicinal prescription and as regards pharmacovigilance’ COM(2011) 633 final — 2008/0256 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended Proposal for a Directive of the European Parliament and of the Council Amending Directive 2001/83/EC, as regards information to the general public on medicinal products subject to medicinal prescription and as regards pharmacovigilance’ COM(2011) 633 final — 2008/0256 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended Proposal for a Directive of the European Parliament and of the Council Amending Directive 2001/83/EC, as regards information to the general public on medicinal products subject to medicinal prescription and as regards pharmacovigilance’ COM(2011) 633 final — 2008/0256 (COD)
OJ C 143, 22.5.2012, p. 147–147
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
22.5.2012 |
EN |
Official Journal of the European Union |
C 143/147 |
Opinion of the European Economic and Social Committee on the ‘Amended Proposal for a Directive of the European Parliament and of the Council Amending Directive 2001/83/EC, as regards information to the general public on medicinal products subject to medicinal prescription and as regards pharmacovigilance’
COM(2011) 633 final — 2008/0256 (COD)
2012/C 143/31
On 28 November 2011, the Council decided to consult the European Economic and Social Committee, under Article 114 and Article 168(2)(c) of the Treaty on the Functioning of the European Union, on the
Amended Proposal for a Directive of the European Parliament and of the Council amending Directive 2001/83/EC, as regards information to the general public on medicinal products subject to medicinal prescription and as regards pharmacovigilance
COM(2011) 633 final – 2008/0256 (COD).
Since the Committee has already set out its views on the subject of the proposal in question in its opinion CESE 1022/2009, adopted on 10 June 2009 (1), it decided, at its 478th plenary session of 22 and 23 February 2012 (meeting of 22 February), by 135 votes in favour with 7 abstentions, not to draw up a new opinion on the subject, but to refer to the position it had taken in the above-mentioned document.
Brussels, 22 February 2012.
The President of the European Economic and Social Committee
Staffan NILSSON
(1) OJ C 306, 16.12.2009, p. 18.